Talk:Primary aldosteronism

(Redirected from Talk:Conn's syndrome)
Latest comment: 1 year ago by Prototyperspective in topic New CT scan for diagnosis

Free review

edit

doi:10.1111/j.1365-2265.2007.02775.x JFW | T@lk 10:52, 30 May 2008 (UTC)Reply

Prevalence

edit

11% in resistant hypertension only, hence probably overreported in the past doi:10.1016/S0140-6736(08)60834-X JFW | T@lk 21:41, 27 August 2008 (UTC)Reply

Conn's Syndrome is caused by an adenoma

edit

Restriction of Conn's to adenoma - according to whom??? That's really not what we've been taught in the UK. Just leave it alone don't start making up stuff yourself on here. —Preceding unsigned comment added by 78.150.52.65 (talk) 21:07, 23 March 2009 (UTC)Reply

It's a widely recognized distinction - Harrison's Principles of Internal Medicine describes Conn Syndrome as an aldosterone-producing adrenal adenoma (Ch 342: Chapter 342. Disorders of the Adrenal Cortex). Most cases of primary hyperaldosteronism are not caused by Conn Syndrome, although Conn's Syndrome is a type of primary hyperaldosteronism. The restriction is a fair one, and not invented by a wikipedia editor. Rytyho usa (talk) 21:14, 10 March 2013 (UTC)Reply

Guideline

edit

doi:10.1210/jc.2015-4061 JFW | T@lk 14:49, 7 March 2016 (UTC)Reply

New CT scan for diagnosis

edit

It may be good to briefly mention this here in the diagnosis section or elsewhere, at least once a review picks up on it (maybe check if there is a review on this in a few years if that's needed). It's featured in 2023 in science like so:

a non-invasive alternative to difficult rarely-used catheter testing for a common cause of high blood pressure is reported (16 Jan).[1][2]

References

  1. ^ "New CT scan helps detect curable form of high blood pressure". New Atlas. 17 January 2023. Archived from the original on 16 February 2023. Retrieved 16 February 2023.
  2. ^ Wu, Xilin; Senanayake, Russell; Goodchild, Emily; et al. (January 2023). "[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial". Nature Medicine. 29 (1): 190–202. doi:10.1038/s41591-022-02114-5. ISSN 1546-170X. PMC 9873572. PMID 36646800.

Prototyperspective (talk) 16:20, 9 March 2023 (UTC)Reply